# Optimal Volume of Bupivacaine in Adductor Canal Nerve Block

> **NCT02557386** · PHASE4 · UNKNOWN · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 60 (estimated)

## Conditions studied

- Anesthesia, Local

## Interventions

- **DRUG:** Levobupivacaine 5 mL
- **DRUG:** Levobupivacaine 10 mL
- **DRUG:** Levobupivacaine 15 mL
- **DRUG:** Levobupivacaine 20 mL
- **DRUG:** Levobupivacaine 25 mL
- **DRUG:** Levobupivacaine 30 mL

## Key facts

- **NCT ID:** NCT02557386
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557386, "Optimal Volume of Bupivacaine in Adductor Canal Nerve Block". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02557386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*